pargyline has been researched along with n-methyl-n-(2-pentyl)propargylamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulton, AA; Davis, BA; Yu, PH | 1 |
| Lai, CT; Yu, PH; Zuo, DM | 1 |
| Barber, A; Boulton, AA; Davis, BA; Durden, DA; Nicklas, WG; Terleckyj, I; Yu, PH | 1 |
| Barber, AJ; Boulton, AA; Yu, PH | 1 |
| Lai, CT; Yu, PH | 1 |
1 review(s) available for pargyline and n-methyl-n-(2-pentyl)propargylamine
| Article | Year |
|---|---|
Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Mice; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Structure-Activity Relationship | 1995 |
4 other study(ies) available for pargyline and n-methyl-n-(2-pentyl)propargylamine
| Article | Year |
|---|---|
Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?
Topics: Animals; Brain; Enzyme-Linked Immunosorbent Assay; Male; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Wistar; Selegiline; Superoxide Dismutase; Time Factors | 1994 |
Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amines; Amphetamines; Animals; Benzylamines; Brain; Catecholamines; Caudate Nucleus; Hypothalamus; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotoxins; Pargyline; Serotonin | 1994 |
Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice.
Topics: Aging; Animals; Behavior, Animal; Body Weight; Brain; Drinking; Isoenzymes; Locomotion; Male; Memory; Mice; Monoamine Oxidase Inhibitors; Pargyline; Selegiline; Time Factors | 1993 |
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Dopamine; Drug Synergism; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Pargyline; Propylamines; Reactive Oxygen Species; Selegiline; Tumor Cells, Cultured | 1997 |